Skip to content

Joiemhil Jemicca Oria Ocariza

NPI 1104542877ActiveIndividual· Nurse Practitioner· Los Angeles, CA

Nurse Practitioner in Los Angeles, California, licensed in CA, with an NPI issued in October 2022. Part D covered 634 prescriptions written in 2024, 91% of them generic. Lilly USA, LLC was the largest of 3 companies reporting payments in 2025, $130.75 in all, mostly food and beverage.

Overview

NPI1104542877
StatusActive
Entity typeIndividual
Sole proprietorYes
NPI issuedOct 14, 2022
Last updated in NPPESJul 21, 2023
Certified by providerJul 21, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nurse Practitioner (CA)

Part D prescriptions in 2024

Prescriptions (claims)634 · 786 30-day fills
Patients78
Total drug cost$37,237
Generic share91% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$130.75 · 5 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Lilly USA, LLC$74.553
Merck Sharp & Dohme LLC$31.071
Novo Nordisk Inc$25.131

What the 2025 payments were for

  • Food and Beverage$130.75 · 5 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other nurse practitioners in Los Angeles

All 550 nurse practitioners in Los Angeles · All nurse practitioners in California